Inositol is not therapeutic in Parkinson's Disease

Alex Mishori; Joseph Levine; Esther Kahana; R. H. Belmaker

doi:10.1002/(SICI)1099-1077(199906)14:4<271::AID-HUP86>3.0.CO;2-I

Inositol is not therapeutic in Parkinson's Disease

Alex Mishori
, Joseph Levine
, Esther Kahana
, R. H. Belmaker

Psychiatry Division

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Abstract

Inositol 12 g per day was added to ongoing anti-Parkinson therapy in a controlled randomized cross-over design in nine patients. No therapeutic effect was found.

Original language	English
Pages (from-to)	271-272
Number of pages	2
Journal	Human Psychopharmacology
Volume	14
Issue number	4
DOIs	https://doi.org/10.1002/(SICI)1099-1077(199906)14:4<271::AID-HUP86>3.0.CO;2-I
State	Published - 1 Jun 1999

Keywords

Dopamine
Inositol
Parkinson's Disease
Second messengers

ASJC Scopus subject areas

Neurology
Clinical Neurology
Psychiatry and Mental health
Pharmacology (medical)

Access to Document

10.1002/(SICI)1099-1077(199906)14:4<271::AID-HUP86>3.0.CO;2-I

Cite this

@article{ccb3727675a144528b4273ae0153026f,

title = "Inositol is not therapeutic in Parkinson's Disease",

abstract = "Inositol 12 g per day was added to ongoing anti-Parkinson therapy in a controlled randomized cross-over design in nine patients. No therapeutic effect was found.",

keywords = "Dopamine, Inositol, Parkinson's Disease, Second messengers",

author = "Alex Mishori and Joseph Levine and Esther Kahana and Belmaker, \{R. H.\}",

year = "1999",

month = jun,

day = "1",

doi = "10.1002/(SICI)1099-1077(199906)14:4<271::AID-HUP86>3.0.CO;2-I",

language = "English",

volume = "14",

pages = "271--272",

journal = "Human Psychopharmacology",

issn = "0885-6222",

publisher = "John Wiley and Sons Ltd",

number = "4",

}

TY - JOUR

T1 - Inositol is not therapeutic in Parkinson's Disease

AU - Mishori, Alex

AU - Levine, Joseph

AU - Kahana, Esther

AU - Belmaker, R. H.

PY - 1999/6/1

Y1 - 1999/6/1

N2 - Inositol 12 g per day was added to ongoing anti-Parkinson therapy in a controlled randomized cross-over design in nine patients. No therapeutic effect was found.

AB - Inositol 12 g per day was added to ongoing anti-Parkinson therapy in a controlled randomized cross-over design in nine patients. No therapeutic effect was found.

KW - Dopamine

KW - Inositol

KW - Parkinson's Disease

KW - Second messengers

UR - https://www.scopus.com/pages/publications/0032973166

U2 - 10.1002/(SICI)1099-1077(199906)14:4<271::AID-HUP86>3.0.CO;2-I

DO - 10.1002/(SICI)1099-1077(199906)14:4<271::AID-HUP86>3.0.CO;2-I

M3 - Article

AN - SCOPUS:0032973166

SN - 0885-6222

VL - 14

SP - 271

EP - 272

JO - Human Psychopharmacology

JF - Human Psychopharmacology

IS - 4

ER -

Inositol is not therapeutic in Parkinson's Disease

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this